THE DIFFERENTIAL RESPONSE TO INTERFERON-GAMMA BY NORMAL AND TRANSFORMED ENDOTHELIAL-CELLS

被引:17
作者
MAIER, JAM
MORELLI, D
BALSARI, A
机构
[1] IST NAZL TUMORI,I-20133 MILAN,ITALY
[2] IST PATOL GEN,MILAN,ITALY
关键词
D O I
10.1006/bbrc.1995.2325
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferon gamma, a multifunctional cytokine secreted by activated T lymphocytes and NK cells, induces normal endothelial cell apoptosis which is inhibited by the activation of protein kinase C. Interestingly, interferon exerts a dual effect on transformed endothelial cell proliferation: at low concentrations it stimulates their growth, while at high concentrations it exerts an inhibitory effect. The different response of normal and transformed endothelial cells correlates with the levels of interferon receptor: when expressed at high levels -such as in normal cells- interferon promotes apoptosis; on the contrary, when cells possess a low number of receptors - such as transformed cells - the cytokine promotes cell growth. Since interferon induces it own receptor, we anticipate that transformed cells exposed to high doses of interferon may upregulate the receptor and, consequently, respond to the cytokine with a reduction in cell viability. (C) 1995 Academic Press, Inc.
引用
收藏
页码:582 / 588
页数:7
相关论文
共 19 条
[1]   THE INTERFERONS - MECHANISMS OF ACTION AND CLINICAL-APPLICATIONS [J].
BARON, S ;
TYRING, SK ;
FLEISCHMANN, WR ;
COPPENHAVER, DH ;
NIESEL, DW ;
KLIMPEL, GR ;
STANTON, GJ ;
HUGHES, TK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (10) :1375-1383
[2]   APOPTOTIC CELL-DEATH INDUCED BY C-MYC IS INHIBITED BY BCL-2 [J].
BISSONNETTE, RP ;
ECHEVERRI, F ;
MAHBOUBI, A ;
GREEN, DR .
NATURE, 1992, 359 (6395) :552-554
[3]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[4]   IMMUNE INTERFERON ACTIVATES MULTIPLE CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX GENES AND THE ASSOCIATED INVARIANT CHAIN GENE IN HUMAN-ENDOTHELIAL CELLS AND DERMAL FIBROBLASTS [J].
COLLINS, T ;
KORMAN, AJ ;
WAKE, CT ;
BOSS, JM ;
KAPPES, DJ ;
FIERS, W ;
AULT, KA ;
GIMBRONE, MA ;
STROMINGER, JL ;
POBER, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (15) :4917-4921
[5]   THE IMPLICATIONS OF ANGIOGENESIS FOR THE BIOLOGY AND THERAPY OF CANCER METASTASIS [J].
FIDLER, IJ ;
ELLIS, LM .
CELL, 1994, 79 (02) :185-188
[6]   ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[7]   INHIBITION OF ENDOTHELIAL-CELL PROLIFERATION BY GAMMA-INTERFERON [J].
FRIESEL, R ;
KOMORIYA, A ;
MACIAG, T .
JOURNAL OF CELL BIOLOGY, 1987, 104 (03) :689-696
[8]  
FUKS Z, 1994, CANCER RES, V54, P2582
[9]   DOES IMPROVED CONTROL OF TUMOR-GROWTH REQUIRE AN ANTICANCER THERAPY TARGETING BOTH NEOPLASTIC AND INTRATUMORAL ENDOTHELIAL-CELLS [J].
GASPARINI, G ;
HARRIS, AL .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (02) :201-206
[10]  
HIKADA H, 1987, TRENDS PHARMACOL SCI, V8, P162